Comments on: Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing’s disease

Comments on: Lundbeck receives orphan drug designation in Japan for asedebart for the treatment of patients with congenital adrenal hyperplasia and Cushing’s disease https://9krapalm.com/lundbeck-receives-orphan-drug-designation-in-japan-for-asedebart-for-the-treatment-of-patients-with-congenital-adrenal-hyperplasia-and-cushings-disease/ เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm Mon, 18 May 2026 10:15:19 +0000 hourly 1 https://wordpress.org/?v=6.9.4